Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CX-024414 for Covid-19 prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 50 adverse event reports in the FDA FAERS database where CX-024414 was used for Covid-19 prophylaxis.

Most Reported Side Effects for CX-024414

Side Effect Reports % Deaths Hosp.
Fatigue 117 16.9% 4 32
Pyrexia 89 12.8% 0 26
Headache 87 12.6% 4 19
Pain 81 11.7% 0 18
Nausea 69 10.0% 2 10
Chills 64 9.2% 0 18
Pain in extremity 59 8.5% 0 13
Arthralgia 49 7.1% 0 11
Diarrhoea 45 6.5% 3 12
Malaise 40 5.8% 2 9
Asthenia 39 5.6% 2 19
Rash 38 5.5% 0 18
Drug ineffective 36 5.2% 1 12
Dyspnoea 36 5.2% 3 17
Pruritus 36 5.2% 0 8

Other Indications for CX-024414

Covid-19 immunisation (385) Product used for unknown indication (91) Immunisation (24) Covid-19 (22) Prophylaxis (13)

Other Drugs Used for Covid-19 prophylaxis

CILGAVIMAB\TIXAGEVIMAB (1,105) COVID-19 VACCINE NOS (583) TOZINAMERAN (377) ELASOMERAN (152) ALCOHOL (136) AZD-1222 (105) AD26.COV2.S (64) COVID-19 VACCINE (52) HYDROXYCHLOROQUINE (52) CASIRIVIMAB\IMDEVIMAB (51)

Related Pages

CX-024414 Full Profile All Covid-19 prophylaxis Drugs CX-024414 Demographics CX-024414 Timeline